Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
Ted Myles has been appointed as the new Chief Executive Officer of Cellarity, a life sciences company, and will also serve as CEO-Partner at Flagship Pioneering, according to a press release.
Avant Technologies and Ainnova Tech have begun acquisition discussions to strengthen their position in AI-driven healthcare, ahead of an FDA pre-submission meeting.
Apexon has announced a strategic partnership with Dataiku to enhance AI adoption in regulated sectors such as banking and healthcare.
PackGene Biotech, Inc. will present its latest advancements in scalable AAV manufacturing and AI-driven capsid engineering at the ASGCT 2025 meeting in New Orleans, according to a press release.
VUNO's AI-powered cardiac arrest risk management system, DeepCARS, has received CE MDR and UKCA certifications, accelerating its market expansion in Europe and the Middle East.
Amplifier Health has partnered with Xeomics to access voice data from over 750,000 patients, advancing their acoustic AI technology for healthcare diagnostics.
Eli Lilly and Company plans to invest up to $250 million in its collaboration with Purdue University to accelerate pharmaceutical innovation over the next eight years.
Clarium has raised $27 million in a Series A funding round led by Northzone to scale its AI-powered supply chain resiliency platform for healthcare systems.
The AI in Pathology Market is projected to grow from $87.2 million in 2024 to $347.4 million by 2030, driven by advancements in digital pathology and telepathology.
Petfolk has selected Radimal as its exclusive teleradiology provider, integrating AI-powered radiology and specialist support across its U.S. clinics.
ACTO has appointed Lori Tierney, former President of Johnson & Johnson Vision, to its Board of Directors to enhance its AI-first platform in life sciences.
The Global Ovarian Cancer Research Consortium has partnered with Microsoft's AI for Good Lab to launch a $1 million grant aimed at improving ovarian cancer survival rates.
OpenAI has engaged in discussions with the FDA about using AI to expedite drug evaluations, focusing on a project called cderGPT.
Phenomix Sciences and Mayo Clinic have developed an AI algorithm to predict nausea risk from GLP-1 therapies, enhancing personalized obesity care.
Carta Healthcare has raised $18.25 million in Series B1 funding to enhance its AI-driven clinical data abstraction and analytics services, announced in a press release.
ODAIA has announced a new AI-powered marketing orchestration solution for pharma, enhancing personalized engagement with healthcare professionals.
HighPeak, backed by Prudential, has launched an AI-driven platform to provide financial advisors with precise forecasts of healthcare costs, as announced in a press release.
Benchling and Moderna have announced an expanded collaboration to integrate AI-driven research across Moderna's R&D operations, enhancing scientific workflows and data management.
Zilia Inc. has closed a bridge financing round with participation from Linearis Ventures and existing investors to advance its oculomics platform.
Inductive Bio has raised $25 million in Series A funding to enhance its AI platform for small molecule drug discovery, announced in a press release. The funding round was led by Obvious Ventures with participation from Andreessen Horowitz and Lux Capital.
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
